Nyra Medical
Atlanta, US · Founded 2018 · Delaware corporation · 4 known investors
Find your way into Nyra Medical
53 people in our graph share verified history with the Nyra Medical team — schools, employers, funds. One of them is your warm intro.
Azin Parhizgarunlockedknows Lori Chmura · together at Soundbite Medical Solutions Inc. (overlapped)
×2knows the team · via Covidien Surgical Devices
knows the team · via Datascope
×3knows the team · via Nyra Medical
×5knows the team · via Southern Connecticut State University
Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function. It targets both TEER-suitable patients and those with limited existing treatment options in the cardiology/medical device field.
Founders & leadership
Nyra Medical was founded in 2018 by Dr. Murali Padala, Dr. Eric Sarin, Dr. Kirthana Suresh, and Sai Muralidhar Padala.
DM
Dr. Murali Padala𝕏Founder
DE
Dr. Eric SarinFounder, Director
DK
Dr. Kirthana SureshFounder
SM
Sai Muralidhar PadalaCo-founder
LC
Lori ChmurainCEOLori Chmura is CEO of Nyra Medical and brings over 20 years of healthcare industry experience in management, sales, clinical operations, and business development, with particular expertise in the cardiovascular medical device space.
GR
Gowri RamanNamed on SEC filing
LW
Lisa Wipperman HeineNamed on SEC filing
Board
AS
Investors · 4
Reported raises · per SEC filings
Form D private placements$12M disclosed across 1 round · 2022
▶$12MraisedNov 2022 · 14 investors · BiotechnologyRule 506(b)
▶$12MraisedNov 2022 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sai Muralidhar PadalaExecutive Officer, Director
- Amrinder SinghDirector
- Eric SarinDirector
- Gowri RamanDirector
- Lisa Wipperman HeineDirector
- Offering amount
- $20M
- Amount sold
- $12M
- Proceeds to insiders
- $100K
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapInsightra Medical5 shared keywordsInsightra Medical develops intra-aortic balloon pump (IABP) catheters used to temporarily support heart function, including a 7Fr IAB catheter kit compatible with Arrow and Datascope consoles. The products are FDA-cleared medical devices intended for use by medical professionals in cardiac catheterization settings.
Cardiovalve5 shared keywordsCardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery. The device targets structural heart disease and is currently restricted to research use.
Supira Medical4 shared keywordsSupira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock. It is a cardiovascular medical device company formed by the Shifamed innovation hub.
Highlife Medical4 shared keywordsHighLife develops a transcatheter mitral valve replacement (TMVR/TSMVR) technology for patients with moderate to severe mitral regurgitation, implanted in a beating heart while preserving the native valve structure. The medical device company operates across Europe, the USA and Australia, with valves manufactured in Irvine, California.
4C Medical Technologies3 shared keywords4C Medical develops minimally invasive medical devices for structural heart disease, including mitral and tricuspid valve treatments. The company serves interventional cardiologists and patients requiring catheter-based cardiac interventions.
Companies competing with Nyra Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Nyra Medical do?
- Nyra Medical develops the CARLEN (Cardiac Leaflet Enhancer) system, a transcatheter single-leaflet device for repairing functional mitral regurgitation while preserving native valve function. It targets both TEER-suitable patients and those with limited existing treatment options in the cardiology/medical device field.
- Who founded Nyra Medical?
- Nyra Medical was founded by Dr. Murali Padala, Dr. Eric Sarin, Dr. Kirthana Suresh, Sai Muralidhar Padala in 2018.
- Who are Nyra Medical's investors?
- Nyra Medical's investors include Broadview Ventures, Epidarex Capital, Vensana Capital, GRA Venture.
- How much funding has Nyra Medical raised?
- Nyra Medical has disclosed $12M raised across 1 round.
- Where is Nyra Medical headquartered?
- Nyra Medical is headquartered in Atlanta, US.